Literature DB >> 24879449

Arrhythmic syncope in neurogenic orthostatic hypotension: two case reports.

Cristina Di Stefano1, Valeria Milazzo, Gabriele Sobrero, Agnese Ravera, Simona Maule, Franco Veglio.   

Abstract

Patients with autonomic failure experience orthostatic hypotension (OH) often leading to syncope. Arrhythmias may cause severe syncope, characterized by an increased risk of mortality. We report two cases of patients with primary autonomic neuropathy suffering from both severe OH and arrhythmic syncope.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24879449     DOI： 10.1007/s10286-014-0246-x

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN： 0959-9851            Impact factor:   4.435


  6 in total

1.  EFNS guidelines on the diagnosis and management of orthostatic hypotension.

Authors:  H Lahrmann; P Cortelli; M Hilz; C J Mathias; W Struhal; M Tassinari
Journal:  Eur J Neurol       Date:  2006-09       Impact factor: 6.089

2.  Peri-operative atrioventricular block as a result of chemotherapy with epirubicin and paclitaxel.

Authors:  D W Wheeler; T V Liew; A R Bailey
Journal:  Anaesthesia       Date:  2007-02       Impact factor: 6.955

3.  Guidelines for the diagnosis and management of syncope (version 2009).

Authors:  Angel Moya; Richard Sutton; Fabrizio Ammirati; Jean-Jacques Blanc; Michele Brignole; Johannes B Dahm; Jean-Claude Deharo; Jacek Gajek; Knut Gjesdal; Andrew Krahn; Martial Massin; Mauro Pepi; Thomas Pezawas; Ricardo Ruiz Granell; Francois Sarasin; Andrea Ungar; J Gert van Dijk; Edmond P Walma; Wouter Wieling
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

4.  Left ventricular hypertrophy in patients with autonomic failure.

Authors:  Simona Maule; Alberto Milan; Tiziana Grosso; Franco Veglio
Journal:  Am J Hypertens       Date:  2006-10       Impact factor: 2.689

5.  A phase II study of high-dose epirubicin (EPI) plus cyclophosphamide (CPA) with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors: a trial of the Japan Clinical Oncology Group.

Authors:  S Takashima; T Saeki; I Adachi; T Watanabe; Y Sasaki; H Murai; T Tabei; M Ogita; M Sano; K Kanda; M Shimoyama
Journal:  Jpn J Clin Oncol       Date:  1997-10       Impact factor: 3.019

6.  Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson's disease.

Authors:  Eva Stuebner; Ekawat Vichayanrat; David A Low; Christopher J Mathias; Stefan Isenmann; Carl-Albrecht Haensch
Journal:  Front Neurol       Date:  2013-05-15       Impact factor: 4.003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.